跳至主要内容
临床试验/ACTRN12605000175673
ACTRN12605000175673终止4 期

INFLAMMATION and VASCULAR FUNCTION in ACUTE STROKE and TIA: TREATMENT WITH ATORVASTATIN and IRBESARTA

niversity of Western Australia0 个研究点目标入组 40 人开始时间: 2005年8月19日最近更新:
适应症

试验速览

阶段
4 期
状态
终止
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
ot stated 至 ot stated(—)
性别
All

入选标准

  • Patients presenting to facilities of the North Metropolitan Area Health Service within 10 days of acute ischaemic stroke.

排除标准

  • Finger prick or laboratory blood sugar level > 13 mmol/L at baseline; - Acute co morbid condition (such as myocardial ischaemia or sepsis); - Pre-menopausal female; - Haemorrhage seen on initial CT.Statin exclusion criteria: - History of sensitivity to statins; - Active liver disease or unexplained elevation in transaminasesIrbesartan exclusion criteria: - Hypotension (SBP< 100mmHg or DBP<70mmHg); - Hypertension (>220 mmHg) or clinical imperative to lower blood pressure hyperkalaemia: >5.5 mmol/L; - History of sensitivity to ATRA; - Renal impairment (defined as creatinine >120 umol/L); - Current treatment with an ATRA or more than one of an ACE inhibitor, non steroidal anti-inflammatory, potassium sparing diuretic, potassium salt or cyclosporin.

研究者

发起方
niversity of Western Australia

相似试验

INFLAMMATION and VASCULAR FUNCTION in ACUTE STROKE... | 临床试验